163 related articles for article (PubMed ID: 34818598)
1. Rapid identification of papillary thyroid carcinoma and papillary microcarcinoma based on serum Raman spectroscopy combined with machine learning models.
Song H; Dong C; Zhang X; Wu W; Chen C; Ma B; Chen F; Chen C; Lv X
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102647. PubMed ID: 34818598
[TBL] [Abstract][Full Text] [Related]
2. Rapid diagnosis of papillary thyroid carcinoma with machine learning and probe electrospray ionization mass spectrometry.
Wang Y; Chen Z; Shima K; Zhong D; Yang L; Wang Q; Jiang R; Dong J; Lei Y; Li X; Cao L
J Mass Spectrom; 2022 Jun; 57(6):e4831. PubMed ID: 35562642
[TBL] [Abstract][Full Text] [Related]
3. Machine learning reveals salivary glycopatterns as potential biomarkers for the diagnosis and prognosis of papillary thyroid cancer.
Ren X; Shu J; Wang J; Guo Y; Zhang Y; Yue L; Yu H; Chen W; Zhang C; Ma J; Li Z
Int J Biol Macromol; 2022 Aug; 215():280-289. PubMed ID: 35660041
[TBL] [Abstract][Full Text] [Related]
4. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
5. RAMAN spectroscopy imaging improves the diagnosis of papillary thyroid carcinoma.
Rau JV; Graziani V; Fosca M; Taffon C; Rocchia M; Crucitti P; Pozzilli P; Onetti Muda A; Caricato M; Crescenzi A
Sci Rep; 2016 Oct; 6():35117. PubMed ID: 27725756
[TBL] [Abstract][Full Text] [Related]
6. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings.
Park YJ; Kim YA; Lee YJ; Kim SH; Park SY; Kim KW; Chung JK; Youn YK; Kim KH; Park DJ; Cho BY
Head Neck; 2010 Jan; 32(1):38-45. PubMed ID: 19475551
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnostic value of the ResNet50, random forest, and DS ensemble models for papillary thyroid carcinoma and other thyroid nodules.
Deng C; Han D; Feng M; Lv Z; Li D
J Int Med Res; 2022 Apr; 50(4):3000605221094276. PubMed ID: 35469474
[No Abstract] [Full Text] [Related]
8. Machine learning-based multiparametric MRI radiomics for predicting the aggressiveness of papillary thyroid carcinoma.
Wang H; Song B; Ye N; Ren J; Sun X; Dai Z; Zhang Y; Chen BT
Eur J Radiol; 2020 Jan; 122():108755. PubMed ID: 31783344
[TBL] [Abstract][Full Text] [Related]
9. Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status.
Mussazhanova Z; Matsuda K; Naruke Y; Mitsutake N; Stanojevic B; Rougounovitch T; Saenko V; Suzuki K; Nishihara E; Hirokawa M; Ito M; Nakashima M
Histopathology; 2013 Nov; 63(5):726-34. PubMed ID: 24004175
[TBL] [Abstract][Full Text] [Related]
10. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
11. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.
Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA
J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813
[TBL] [Abstract][Full Text] [Related]
12. Prognosis and growth activity depend on patient age in clinical and subclinical papillary thyroid carcinoma.
Ito Y; Miyauchi A; Kobayashi K; Miya A
Endocr J; 2014; 61(3):205-13. PubMed ID: 24212880
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Algorithms for the Prediction of Central Lymph Node Metastasis in Patients With Papillary Thyroid Cancer.
Wu Y; Rao K; Liu J; Han C; Gong L; Chong Y; Liu Z; Xu X
Front Endocrinol (Lausanne); 2020; 11():577537. PubMed ID: 33193092
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
[TBL] [Abstract][Full Text] [Related]
15. Machine learning-based prediction model using clinico-pathologic factors for papillary thyroid carcinoma recurrence.
Park YM; Lee BJ
Sci Rep; 2021 Mar; 11(1):4948. PubMed ID: 33654166
[TBL] [Abstract][Full Text] [Related]
16. Application of serum mid-infrared spectroscopy combined with an ensemble learning method in rapid diagnosis of gliomas.
Qu H; Wu W; Chen C; Yan Z; Guo W; Meng C; Lv X; Chen F; Chen C
Anal Methods; 2021 Oct; 13(39):4642-4651. PubMed ID: 34545384
[TBL] [Abstract][Full Text] [Related]
17. Risk of papillary thyroid carcinoma and nodular goiter associated with exposure to semi-volatile organic compounds: A multi-pollutant assessment based on machine learning algorithms.
Wang F; Lin Y; Xu J; Wei F; Huang S; Wen S; Zhou H; Jiang Y; Wang H; Ling W; Li X; Yang X
Sci Total Environ; 2024 Mar; 915():169962. PubMed ID: 38219999
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
19. Controversies in papillary microcarcinoma of the thyroid.
Piersanti M; Ezzat S; Asa SL
Endocr Pathol; 2003; 14(3):183-91. PubMed ID: 14586064
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of papillary thyroid carcinoma by
Wang T; Sun Z; Wang Y; Li F; Zhou X; Tian X; Wang S
Drug Discov Ther; 2020 Sep; 14(4):187-196. PubMed ID: 32848112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
